Navigation Links
Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
Date:4/21/2008

ort materials that provide best practices on patient selection, device implantation and patient discharge and follow-up to ensure optimal patient outcomes. In addition, we are implementing programs to educate referring cardiologists about the compelling data from our trial and to increase their understanding of and appreciation for the value of mechanical circulatory support available with the HeartMate II," Burbach continued.

"For a population having an unmet need and for which drug therapies have not proven to be an effective solution, we believe the HeartMate II represents a breakthrough therapy and new hope for these patients. It further demonstrates our leadership position in the mechanical circulatory support arena with the broadest portfolio of devices. We want to acknowledge the efforts of the clinicians and patients who participated in this landmark trial in making this day a reality," Burbach commented.

About HeartMate II

The HeartMate II is a mechanical circulatory support device intended for a broad range of advanced-stage heart failure patients. An axial flow device, the HeartMate II can pump up to 10 liters of blood per minute, the full output of a healthy heart, and is designed to provide long-term cardiac support. The device is implanted alongside a patient's native heart and takes over the pumping ability of the weakened heart's left ventricle. It is easier to implant than prior devices, and with only one moving part, the HeartMate II is designed to provide exceptional reliability and improved patient quality of life. The device is designed to have a much longer functional life than the previous generation of devices and to operate more simply and quietly.

About Thoratec

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate LVAS with more than 11,000 devices implanted in patients suffering fr
'/>"/>

SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
2. Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein
3. Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
4. InterMune Announces Progress on Pirfenidone in IPF
5. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
6. Aida Announces New Anti-Cancer Drug Under Development
7. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
8. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
10. ViroPharma Announces Discontinuation of HCV-796 Development
11. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... has completed the sale to Galderma of all rights ... held by Valeant for $1.4 billion in cash, pursuant ... recently completed its acquisition of Galderma. ... products to a company that is firmly committed to ...
(Date:7/10/2014)... -- Decision Resources Group finds that over half of ... Drug Administration,s (FDA) approval of Vifor Fresenius Medical Care ... by the FDA in November 2013 for the treatment ... dialysis. Other key findings from the report ... : , Bundling: Based ...
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... Speaking today at the plenary session of ... Klaus Schwamborn, CDO of Pepscan Therapeutics, presented Pepscan,s protein ... In his presentation ,CLIPS meets GPCRs, Dr. Schwamborn ... of immunogen design. He showed data demonstrating that Pepscan,s ...
... announced that Leroy Hood, MD, PhD, a world recognized leader ... Scientific Advisory Board.  "High multiplex qPCR diagnostics ... clinic," commented Dr. Hood.  "I am delighted to help PrimeraDx ... to a robust molecular diagnostics solution." "Lee brings ...
Cached Medicine Technology:Pepscan Therapeutics Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference 2PrimeraDx Appoints Leroy Hood to its Scientific Advisory Board 2
(Date:7/13/2014)... 2014 A decreased ability to identify odors ... Alzheimer,s disease, while examinations of the eye could ... with Alzheimer,s, in the brain, according to the ... the Alzheimer,s Association International Conference 2014 (AAIC 2014) ... the decreased ability to identify odors was significantly ...
(Date:7/13/2014)... 2014 Celebrity fitness trainer and former ... promotional partnership with Aqua Health Labs for their flagship ... supplement . The collaboration was recently announced live on ... trainer , actor, model, and a two time World ... celebrities, he has prepared stars including Demi Moore, Hilary ...
(Date:7/13/2014)... According to The Peripheral Neuropathy Program review ... that teaches people how to deal with diabetic nerve ... This program also provides people with safe and effective ... including numbness, prickling, burning, and intense stabbing pains. ... treatment program can help people eliminate some types of ...
(Date:7/12/2014)... Recently, Fadhits.com, a well-known wedding dress manufacturer and retailer, has ... to its product line. In addition, the company has ... to bring more benefits for its loyal fans. All ... up to 72% off. , As a leader in the ... shop is a good place for ladies who want to ...
(Date:7/12/2014)... 12, 2014 Fresh off their respective performances ... will meet on September 5th at Sun Life Stadium in ... see some of the brightest stars in the world of ... Miami will be treated to some of the best talent ... ranked as the third best team in the world according ...
Breaking Medicine News(10 mins):Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 3Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 3
... has improved substantially over the last 35 years in ... improvements in clinical management, according to a study in ... potentially dangerous condition that may develop in late pregnancy ... excessive weight gain, and the presence of protein in ...
... the use of tainted human body parts, lifted off human ... as implants for patients. This information came to light, notwithstanding ... interest take precedence over issues of secrecy, in keeping with ... is thought to be the work of a corpse-robbing gang ...
... who live in far-flung areas run a grave risk of ... an increase in the rates of// heart disease, diabetes and ... Canadian Institute for Health Information. , ,According ... had increased by 14 per cent in the god-forsaken areas ...
... partly attributed to the increased prevalence of the procedure among ... Paltrow have all opted for the C-section and this is ... their example. ,'There's no doubt in my mind ... ignited by the fact that in our pop culture many ...
... treatment mainstay for prostate cancer puts men at increased ... large observational study published in the// Sept. 20 Journal ... have high five-year survival rates, but they also have ... study author Nancy Keating, MD, MPH, assistant professor of ...
... Gawande has won a "no strings attached" $500,000 "genius" ... MacArthur Foundation//. ,Gawande, 40, whose many articles and ... him one of the most recognised of American writers, ... 2006 announced by the Foundation in Chicago Tuesday. ...
Cached Medicine News:Health News:Improvement Seen in Fetal Survival Following Preeclampsia 2Health News:Stolen Body Parts From Human Cadavers used as Implants by 25 UK Hospitals 2Health News:Rural Canadians, Take Care Of Your Health 2Health News:Prostate Cancer Treatment Increases Risk of Diabetes and Heart Disease 2Health News:Indian American Surgeon Wins US "Genius" Award 2
2 tests on one meter. Glucose test for immediate glucose levels. GlucoProtein (Fructosamine) for overall control, average over prior 2-3 weeks. The Duet is the only hand held instrument to perform th...
The DOT-approved A150 test is used for workplace testing, most publicly for federally mandated testing of transportation workers, but also in private company "drug free workplace" programs. Each hash...
... QuickScreen multi-panel dip cards offer minimal exposure ... of any conceivable combination of 9 different ... your drug testing program. Just dip the ... timer tells you when to read the ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
Medicine Products: